Inverse association of long-acting natriuretic peptide with metabolic syndrome in congestive heart failure patients

Table 4 Correlation of fasting serum long-acting natriuretic peptide levels and clinical variables by univariate linear regression analyses among the 98 congestive heart failure patients

Items	Beta	P value
Age (years)	0.214	0.140
Height (cm)	−0.070	0.633
Body weight (kg)	−0.370	0.009*
Waist circumference (cm)	−0.259	0.103
Body mass index (BMI; kg/m²)	−0.407	0.004*
Body fat mass (%)	−0.092	0.840
Duration of heart failure (months)	0.050	0.765
White blood count (x1000/ul)	−0.042	0.788
Haemoglobulin (g/dl)	−0.067	0.668
Albumin (g/dl)	−0.100	0.494
Globulin (g/dl)	−0.058	0.692
Total cholesterol (mg/dl)	−0.042	0.776
Triglyceride (mg/dl)	−0.248	0.086
HDL-C (mg/dl)	0.010	0.948
LDL-C (mg/dl)	0.061	0.679
Fasting glucose (mg/dl)	0.218	0.132
Blood urea nitrogen (mg/dl)	0.317	0.026*
Creatinine (mg/dl)	−0.018	0.903
CRP (mg/dl)	−0.162	0.265
HOMA-IR	−0.321	0.024*
HOMA-β	−0.469	0.001*

*P < 0.05 was considered statistically significant after univariate linear analyses.
HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol; CRP, C-reactive protein; HOMA-IR, homeostasis model assessment of insulin resistance; HOMA-β, homeostasis model assessment of beta cell function.

ISSN: 1758-5996